nestle sa-reg (NESN:SIX Swiss Ex)
Last SFr.66.95 CHF
Change Today +0.25 / 0.37%
Volume 9.2M
As of 11:43 AM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).
Financial Statements for nestle sa-reg (NESN)
Year over year, Nestlé S.A. has been able to grow revenues from SFr.83.6B CHF to SFr.92.2B CHF. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 52.76% to 52.50%. This was a driver that led to a bottom line growth from SFr.9.5B CHF to SFr.10.6B CHF.
View Income Statement In U.S. Dollar| Currency in Millions of Swiss Francs | As of: | Dec 31 2009 CHF | Dec 31 2010 Reclassified CHF | Dec 31 2011 Restated CHF | Dec 31 2012 CHF | 4 Year Trend |
| Revenues | 100,579.0 | 87,906.0 | 83,642.0 | 92,186.0 |  | |
| Other Revenues | -- | 109.0 | 128.0 | 138.0 | | |
| TOTAL REVENUES | 100,579.0 | 88,015.0 | 83,770.0 | 92,324.0 | | |
| Cost of Goods Sold | 43,467.0 | 44,775.0 | 44,127.0 | 48,398.0 | | |
| GROSS PROFIT | 57,112.0 | 43,240.0 | 39,643.0 | 43,926.0 | | |
| Selling General & Admin Expenses, Total | 42,533.0 | 27,799.0 | 24,997.0 | 27,855.0 | | |
| R&D Expenses | 1,357.0 | 1,403.0 | 1,423.0 | 1,544.0 | | |
| Other Operating Expenses | -- | 317.0 | 145.0 | 86.0 | | |
| OTHER OPERATING EXPENSES, TOTAL | 43,890.0 | 29,519.0 | 26,565.0 | 29,485.0 | | |
| OPERATING INCOME | 13,222.0 | 13,721.0 | 13,078.0 | 14,441.0 | | |
| Interest Expense | -745.0 | -828.0 | -527.0 | -568.0 | | |
| Interest and Investment Income | 83.0 | 58.0 | 87.0 | 75.0 | | |
| NET INTEREST EXPENSE | -662.0 | -770.0 | -440.0 | -493.0 | | |
| Income (Loss) on Equity Investments | 800.0 | 1,010.0 | 866.0 | 1,060.0 | | |
| Other Non-Operating Income (Expenses) | 6.0 | -6.0 | -9.0 | -23.0 | | |
| EBT, EXCLUDING UNUSUAL ITEMS | 13,366.0 | 13,955.0 | 13,495.0 | 14,985.0 | | |
| Merger & Restructuring Charges | -200.0 | -492.0 | -134.0 | -177.0 | | |
| Impairment of Goodwill | -37.0 | -337.0 | -16.0 | -14.0 | | |
| Gain (Loss) on Sale of Investments | 40.0 | 14.0 | 62.0 | 35.0 | | |
| Gain (Loss) on Sale of Assets | 50.0 | 29.0 | 0.0 | 135.0 | | |
| Other Unusual Items, Total | -581.0 | -778.0 | -491.0 | -453.0 | | |
| Legal Settlements | -411.0 | -584.0 | -341.0 | -378.0 | | |
| EBT, INCLUDING UNUSUAL ITEMS | 12,638.0 | 12,391.0 | 12,916.0 | 14,511.0 | | |
| Income Tax Expense | 3,087.0 | 3,343.0 | 3,112.0 | 3,451.0 | | |
| Minority Interest in Earnings | -291.0 | -271.0 | -317.0 | -449.0 | | |
| Earnings from Continuing Operations | 9,551.0 | 9,048.0 | 9,804.0 | 11,060.0 | | |
| EARNINGS FROM DISCOUNTINUED OPERATIONS | 1,168.0 | 25,456.0 | -- | -- | | |
| NET INCOME | 10,428.0 | 34,233.0 | 9,487.0 | 10,611.0 | | |
| NET INCOME TO COMMON INCLUDING EXTRA ITEMS | 10,428.0 | 34,233.0 | 9,487.0 | 10,611.0 | | |
| NET INCOME TO COMMON EXCLUDING EXTRA ITEMS | 9,260.0 | 8,777.0 | 9,487.0 | 10,611.0 | | |
| Recently Viewed | |||
| NESN:VX | SFr.66.95 CHF | +0.25 |  |
| Company | Last | Change |
| Archer-Daniels-Midland Co | $35.00 USD | +0.84 |
| Novartis AG | SFr.71.75 CHF | -0.45 |
| PepsiCo Inc | $83.80 USD | +0.06 |
| Procter & Gamble Co/The | $80.02 USD | -0.18 |
| Coca-Cola Co/The | $42.97 USD | -0.12 |
| View Industry Companies | ||
Industry Analysis
NESN
Industry Average
| Valuation | NESN | Industry Range |
| Price/Earnings | 19.1x |
|
| Price/Sales | 2.2x |
|
| Price/Book | 3.3x |
|
| Price/Cash Flow | 19.2x |
|
| TEV/Sales | 1.8x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
